Chih-Hsiang Leng has completed his PhD from the National Defense Medical Center, Taiwan and Post-doctoral studies from the Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes (NHRI). He is a Research Fellow and Deputy Director in National Institute of Infectious Diseases and Vaccinology, NHRI. He is now working for the development of novel and effective recombinant subunit-based vaccines. He collaborated with his colleagues to develop novel polymer-based adjuvant for enhancing the potency of subunit vaccines and to establish a novel lipoprotein expression system to produce high potent lipoimmunogens for the development of novel subunit vaccines. Chih-Hsiang Leng has completed his PhD from the National Defense Medical Center, Taiwan and Post-doctoral studies from the Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes (NHRI). He is a Research Fellow and Deputy Director in National Institute of Infectious Diseases and Vaccinology, NHRI. He is now working for the development of novel and effective recombinant subunit-based vaccines. He collaborated with his colleagues to develop novel polymer-based adjuvant for enhancing the potency of subunit vaccines and to establish a novel lipoprotein expression system to produce high potent lipoimmunogens for the development of novel subunit vaccines.

Vaccines & Vaccination